Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kreina Sharela Vega"'
Autor:
Oriol Mirallas, Berta Martin-Cullell, Víctor Navarro, Kreina Sharela Vega, Jordi Recuero-Borau, Diego Gómez-Puerto, Daniel López-Valbuena, Clara Salva de Torres, Laura Andurell, Anna Pedrola, Roger Berché, Fiorella Palmas, José María Ucha, Guillermo Villacampa, Alejandra Rezqallah, Judit Sanz-Beltran, Rafael Bach, Sergio Bueno, Cristina Viaplana, Gaspar Molina, Alberto Hernando-Calvo, Juan Aguilar-Company, María Roca, Eva Muñoz-Couselo, Alex Martínez-Martí, Ada Alonso, Simeon Eremiev, Teresa Macarulla, Ana Oaknin, Cristina Saura, Elena Élez, Enriqueta Felip, Ángeles Peñuelas, Rosa Burgos, Patricia Gómez Pardo, Elena Garralda, Josep Tabernero, Sònia Serradell, Sònia Servitja, David Paez, Rodrigo Dienstmann, Joan Carles
Publikováno v:
The Lancet Regional Health. Europe, Vol 46, Iss , Pp 101063- (2024)
Summary: Background: Prognostic factors for ambulatory oncology patients have been described, including Eastern Cooperative Oncology Group (ECOG), tumor stage and malnutrition. However, there is no firm evidence on which variables best predict mortal
Externí odkaz:
https://doaj.org/article/510c740dd59f414d89fc0806c8cb60c4
Autor:
Kreina Sharela Vega Cano, David Humberto Marmolejo Castañeda, Santiago Escrivá-de-Romaní, Cristina Saura
Publikováno v:
Scientia
Càncer de mama metastàtic; Teràpies dirigides; Trastuzumab Metastatic breast cancer; Targeted therapies; Trastuzumab Cáncer de mama metastásico; Terapias dirigidas; Trastuzumab Approximately 20% of breast cancers (BC) overexpress human epidermal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cddbb7d5005485730de7a29b20be26cf
https://doi.org/10.3390/cancers15010051
https://doi.org/10.3390/cancers15010051
Autor:
Oriol Mirallas, Daniel Lopez Valbuena, Kreina Sharela Vega-Cano, Diego Gómez-Puerto, Berta Martin Cullell, Jordi Recuero-Borau, Clara Salva-Torres, Laura Andurell, Victor Navarro Garces, Sergio Bueno-Salazar, Juan Aguilar-Company, Maria Roca, Ada Alonso, Patricia Gómez Pardo, Angeles Peñuelas, Rodrigo Dienstmann, Sonia Serradell, Sonia Servitja, David Paez, Josep Tabernero
Publikováno v:
Journal of Clinical Oncology. 40:12121-12121
12121 Background: Prognostic factors for oncologic pts after surgery or curative systemic treatment have been described, including ECOG performance status, tumor staging and malnutrition. However, there is no solid evidence on which combination of va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea1572484bac3b13ec6edc8dd658d86b
https://doi.org/10.1200/jco.2022.40.16_suppl.12121
https://doi.org/10.1200/jco.2022.40.16_suppl.12121